Essex Bio-Technology's market cap is currently HK$2.86B. The company's EPS TTM is HK$0.288; its P/E ratio is 9.15; and it has a dividend yield of 2.57%. Essex Bio-Technology is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
